UCI case report suggests antihistamines may provid
Post# of 148110
(Total Views: 499)
Posted On: 03/10/2022 8:16:29 AM
UCI case report suggests antihistamines may provide relief for long COVID sufferers
latimes.com
Under the care of a doctor, she was prescribed a second antihistamine and reported a 90% return of her pre-COVID daily life and fully returned to work.
“We suspect that long COVID may have subtypes and this particular subtype, it may actually target these types of symptoms,” Pinto said.
In the second closely examined case, another healthy, middle-aged white woman reported long COVID symptoms nine months after infection, including brain fog, fatigue and a condition known as “COVID-19 toes.” More than a year after she was infected with COVID-19, she took an antihistamine and, like the first patient, experienced a marked improvement of her brain fog and fatigue the morning after.
Two months after a set dosage under a doctor’s care, she is reporting a 95% return to pre-COVID functioning and has been able to resume exercising.
Those findings are consistent with previous studies published in the Journal of Investigative Medicine as well as Pulmonary Pharmacology & Therapeutics, which both found potential benefits from treating long COVID symptoms with antihistamines.
latimes.com
Under the care of a doctor, she was prescribed a second antihistamine and reported a 90% return of her pre-COVID daily life and fully returned to work.
“We suspect that long COVID may have subtypes and this particular subtype, it may actually target these types of symptoms,” Pinto said.
In the second closely examined case, another healthy, middle-aged white woman reported long COVID symptoms nine months after infection, including brain fog, fatigue and a condition known as “COVID-19 toes.” More than a year after she was infected with COVID-19, she took an antihistamine and, like the first patient, experienced a marked improvement of her brain fog and fatigue the morning after.
Two months after a set dosage under a doctor’s care, she is reporting a 95% return to pre-COVID functioning and has been able to resume exercising.
Those findings are consistent with previous studies published in the Journal of Investigative Medicine as well as Pulmonary Pharmacology & Therapeutics, which both found potential benefits from treating long COVID symptoms with antihistamines.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼